Author

U. Sahu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Dixit· 1 shared A. Kumar· 1 shared G. Agnihotri· 1 shared G. Pages· 1 shared I. Ben-Sahra· 1 shared J. Durivault· 1 shared J. Parola· 1 shared M. Teisseire· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dixit

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploiting De Novo Serine Synthesis as a Metabolic Vulnerability to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma

M. Teisseire, U. Sahu, J. Parola, M.-C. Tsai, V. Vial, J. Durivault, R. Grepin, Y. Cormerais, G. Pages, I. Ben-Sahra, S. Giuliano

This study identifies serine synthesis as a metabolic vulnerability in sunitinib-resistant renal cell carcinoma, showing that inhibiting key enzymes enhances drug sensitivity.

bioRxiv · Mar 22, 2024 · PreprintCancer Biology

A novel multi-epitope peptide vaccine candidate targeting Hepatitis E virus: an in-silico approach

A. Kumar, U. Sahu, G. Agnihotri, A. Dixit, P. Khare

This paper designs a multi-epitope peptide vaccine against Hepatitis E virus using in-silico methods, showing it is immunogenic, stable, and non-allergic.

bioRxiv · Dec 13, 2022Immunology